4//SEC Filing
BALL BRYAN 4
Accession 0001104659-21-003101
CIK 0001270073other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 7:01 PM ET
Size
7.8 KB
Accession
0001104659-21-003101
Insider Transaction Report
Form 4
BALL BRYAN
Chief Quality Officer
Transactions
- Award
Option to Purchase Common Stock
2021-01-11+39,185→ 39,185 totalExercise: $31.26Exp: 2031-01-11→ Common Stock (39,185 underlying) - Award
Common Stock
2021-01-11+25,000→ 25,000 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and the remaining shares vesting pro rata on each subsequent three-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date is January 11, 2021.
- [F2]The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 11, 2021.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001766522
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 7:01 PM ET
- Size
- 7.8 KB